Published by Persistence MarketResearch
Posted on September 23, 2021
6 min readLast updated: February 2, 2026
The Growth Factors Market is set to reach $1.7 Bn by 2031, driven by telehealth advancements and increased demand in oncology and autoimmune research.
The Growth Factors Market will be worth US$ 1.7 Bn at a CAGR of 7.2% between 2021-2031. With seamless digital exploration on the anvil, greater patient volume is likely to be enclosed worldwide with no geographical barriers to hold back. Telehealth is there is added to the digital transformation wave, thereby revolutionizing the healthcare vertical.
As per Persistence Market Research’s latest revised industry analysis, the global growth factors market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a CAGR of close to 7% over the forecast period (2021-2031).
According to the World Health Organization (WHO), cancer caused around 9.9 million deaths worldwide in 2020. In addition, around 19.2 million people across the world were suffering from cancer. Also, increasing occurrence of autoimmune disorders is anticipated to drive demand for growth factors.
Rising prevalence of autoimmune diseases and cancer and the benefits of cytokine and growth factors therapy in the treatment of these diseases are expected to complement market growth over the coming years.
Growing research in the field of wound healing and skin regeneration is also expected to favor expansion of the global growth factors market. However, high cost associated with GMP grade growth factors is estimated to hamper market growth.
Acquisitions, collaborations, and partnership agreements are rife in this landscape:
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4456
Company Profiles:
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4456
Key Takeaways from Market Study
“Rising prevalence of cancer, preference toward use of regenerative medicines, and new product launches & approvals are expected to drive market growth over the coming years,” says an analyst of Persistence Market Research.
Demand-side Drivers:
Market Opportunities:
Access Full Report@ https://www.persistencemarketresearch.com/checkout/4456
Market Competition
New product approvals, launches, collaborations, agreements, and partnerships have emerged as the main growth strategy implemented by leading players. By focusing on these strategies, key market players are strengthening their existing product portfolios to expand their geographic footprints.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the growth factors market in its latest study, presenting a historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on the product (transforming growth factors (TGF), epidermal growth factors (EGFs), platelet-derived growth factors (PDGFs), fibroblast growth factors (FGFs), insulin-like growth factors (IGFs), vascular endothelial growth factors (VEGFs), hepatocyte growth factors (HGFs), tumour necrosis factors (TNFs), interleukins, and others), grade (GMP grade and NON-GMP grade), application (oncology research, haematology research, wound healing research, dermatology research, cardiovascular disease & diabetes, cell therapy and ex vivo manufacturing, and others), and end user (pharmaceutical and biotechnology companies, research centres & academic institutes, and CMOs & CDMOs), across seven key regions of the world.
Related Reports:
Ostomy Drainage Bags Market:
These diseases are common in developed economies, particularly in the urban areas. During and after the surgery, ostomy drainage bags are used to control incontinence and discharge the wastes. Thus, the growing geriatric population is projected to drive the growth of the ostomy drainage bags market.
Peripheral Intravenous Catheters Market:
The global peripheral intravenous catheters market was valued at US$ 4.9 Bn in 2020, and is expected to witness a healthy CAGR of 7% during the forecast period (2020–2030).
Dental CAD/CAM & Dental Prosthesis Market:
In terms of revenue, the global dental CAD/CAM & dental prosthesis market is projected to register a CAGR of 5.6% over the forecast period, owing to various factors, regarding which PMR offers detailed insights and forecast.
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
The post The Growth Factors Market To See Growth Based On Immediate Adoption Of Advancements (Reaching US$ 1.7 Bn) Between 2021-2031 appeared first on Lake Shore Gazette.
The article discusses the growth factors market, projected to reach $1.7 billion by 2031, driven by advancements in telehealth and regenerative medicine.
Key drivers include telehealth advancements, oncology and autoimmune research, and the rising prevalence of cancer and autoimmune diseases.
North America dominates with a 41% share, followed by Europe with a 30% share.
Explore more articles in the Research Reports category
